Does TOCILIZUMAB Cause Bronchopulmonary aspergillosis? 246 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 246 reports of Bronchopulmonary aspergillosis have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 0.3% of all adverse event reports for TOCILIZUMAB.
246
Reports of Bronchopulmonary aspergillosis with TOCILIZUMAB
0.3%
of all TOCILIZUMAB reports
120
Deaths
118
Hospitalizations
How Dangerous Is Bronchopulmonary aspergillosis From TOCILIZUMAB?
Of the 246 reports, 120 (48.8%) resulted in death, 118 (48.0%) required hospitalization, and 31 (12.6%) were considered life-threatening.
Is Bronchopulmonary aspergillosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 246 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Bronchopulmonary aspergillosis?
TACROLIMUS (968)
PREDNISONE (967)
DEXAMETHASONE (854)
CYCLOPHOSPHAMIDE (824)
METHYLPREDNISOLONE (794)
PREDNISOLONE (704)
MYCOPHENOLATE MOFETIL (702)
RITUXIMAB (606)
CYCLOSPORINE (583)
METHOTREXATE (553)
Which TOCILIZUMAB Alternatives Have Lower Bronchopulmonary aspergillosis Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE